Enright S M, Flagstad M S
Department of Pharmacy Services, Shands Hospital, University of Florida, Gainesville.
Am J Hosp Pharm. 1991 Sep;48(9):1908-11.
Societal forces behind the increased use of outcomes to measure the quality of health care are described, and continuous improvement of outcomes as a goal for pharmacy is discussed. Consumerism, the demands of the aging American population, and problems of access to care for many Americans have helped to bring about an examination of quality. The effectiveness of clinical decision-making methods has been challenged. The Joint Commission on Accreditation of Healthcare Organizations now seeks to examine whether quality care is being provided, rather than whether the capacity exists to provide it. Inspection against criteria to determine quality will be superseded by a goal of continuous improvement. Traditional drug-use evaluation needs to go beyond collection of data and confrontation of noncompliant prescribing. Multidisciplinary quality improvement efforts should focus on patient outcomes; the goal should be to prevent all errors, rather than to not exceed some tolerable rate of errors. Pharmacists and risk managers should share information. Documentation of quality assurance efforts will be required. Drug-use evaluations should include assessment for therapeutic failure. Pharmacy quality improvement efforts can improve patient care and expand the pharmacist's role on the health-care team.
文中描述了推动使用医疗结果来衡量医疗质量的社会力量,并讨论了将持续改善医疗结果作为药学目标的问题。消费主义、美国老龄化人口的需求以及许多美国人获得医疗服务的问题促使人们对医疗质量进行审视。临床决策方法的有效性受到了挑战。医疗组织认证联合委员会现在寻求检查是否提供了高质量的医疗服务,而不是是否具备提供高质量医疗服务的能力。以持续改进为目标将取代依据标准进行检查以确定质量的做法。传统的药物使用评估需要超越数据收集和对不规范处方的对抗。多学科质量改进工作应关注患者的医疗结果;目标应该是预防所有错误,而不是不超过某个可容忍的错误率。药剂师和风险管理人员应共享信息。需要记录质量保证工作。药物使用评估应包括对治疗失败的评估。药学质量改进工作可以改善患者护理,并扩大药剂师在医疗团队中的作用。